Live Quote · NASDAQNUVLHealthcare · Biotechnology

Nuvalent, Inc.

$123.96▲ 0.00%(+$0.00)

MKT CAP $9.13BLAST EARNINGS Aug 6, 2026

50%

Bullish

50%

Bullish

TickerSpark Score

57/100

▌ Mixed

67

Valuation

20

Profitability

15

Growth

84

Health

100

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NUVL research report →

Analyst Price Target

$127.32+2.7% vs. today

Range $122.85 – $165

Analyst RatingHold

8 Buy11 Hold0 Sell

Price Chart

+50.33% · this period

52-Week Range100% of range

Low

$71.13

Current

$123.96

High

$123.99

Float & Shares

Free Float: 66.6%
Shares Outstanding: 73.69M
Float Shares: 49.11M

Institutional Ownership

108.1%

of shares held by institutions

269 13F filers

Insider ActivityLast quarter

12 Buys126 Sells

Buy/sell ratio 0.10. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.

13F Holders · NUVL

Top institutional holders

Largest 13F positions, with quarter-over-quarter change.

Holder	Shares	Δ Quarter
Deerfield Management Company, L.P. (Series C)	17.25M	0
Paradigm Biocapital Advisors LP	5.92M	▲ 600.00K
Blackrock, Inc.	5.59M	▲ 760.83K
Vanguard Group Inc	5.24M	▲ 639.26K
Hbk Investments L P	3.48M	▲ 3.48M
Fil Ltd	2.95M	▲ 2.95M
Vanguard Capital Management LLC	2.46M	▲ 30.63K
State Street Corp	2.09M	▲ 55.21K
Deep Track Capital, LP	1.78M	▲ 407.00K
Glazer Capital, LLC	1.77M	▲ 1.77M
Goldman Sachs Group Inc	1.64M	▲ 1.10M
Perceptive Advisors LLC	1.58M	0

ETF Exposure · NUVL

Held by 21 ETFs

Biggest fund positions in NUVL by dollar value.

NJM

0.1% wt$106.20M

NLO

0.3% wt$37.13M

JHMM

0.0% wt$2.18M

HKJ

0.1% wt$1.27M

HKG

0.1% wt$176.93K

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

Date	Insider	Role	Type	Shares	Value
Jul 15, 26	Flynn James E	director, 10 percent owner, other: Director by Deputization	other	5,146	$638.10K
Jul 15, 26	Flynn James E	director, 10 percent owner, other: Director by Deputization	sell	3,444	$427.06K
Jul 15, 26	Flynn James E	director, 10 percent owner, other: Director by Deputization	sell	2,717,627	$0
Jul 15, 26	Flynn James E	director, 10 percent owner, other: Director by Deputization	sell	43,000	$731.00K
Jul 15, 26	Flynn James E	director, 10 percent owner, other: Director by Deputization	sell	20,000	$187.20K
Jul 15, 26	Flynn James E	director, 10 percent owner, other: Director by Deputization	sell	15,000	$670.20K
Jul 15, 26	Flynn James E	director, 10 percent owner, other: Director by Deputization	sell	3,789	$303.23K
Jul 15, 26	Flynn James E	director, 10 percent owner, other: Director by Deputization	sell	4,147	$313.22K
Jul 15, 26	Flynn James E	director, 10 percent owner, other: Director by Deputization	sell	650,000	$80.60M
Jul 15, 26	Meyers Michael L.	director	sell	4,147	$313.22K

A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.

Nuvalent, Inc.

Price Chart

About the company

Get TickerSpark's AI analysis on NUVL

Similar companies

Top institutional holders

Held by 21 ETFs

Recent insider transactions

Our NUVL coverage

No research on NUVL yet